Beryl Capital Management’s Calidi Biotherapeutics CLDI Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-9,667	Closed	-$11.5M	–	54
2022 Q1	$11.5M	Hold	9,667	–	–	0.69%	29
2021 Q4	$11.4M	Buy	+9,667	New	+$11.4M	0.59%	34